Catalyst Wire Dossier Catalyst Wire Dossier

activated CIK armed with bispecific antibody

· Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for activated CIK armed with bispecific antibody, covering 2021-02-01 to 2021-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer [Phase 2]

See pricing